Ambry Genetics

Ambry Genetics, together with its subsidiary Progeny Genetics, is a worldwide leader in hereditary cardiovascular diagnostics and software solutions, offering the industry’s most comprehensive genetic services. Our hereditary cardiovascular test menu features tiered, intuitive approaches to testing for hypertrophic cardiomyopathy (HCM) to minimize turnaround time and help control costs.  As one of the first labs to introduce clinical next generation sequencing (NGS), we also offer comprehensive cardiovascular panels for inherited arrhythmias, cardiomyopathies, aortic aneurysms/dissections, and familial hypercholesterolemia. Full gene sequencing and gross deletion/duplication analysis are performed for all genes (exceptions may be specified). Our most comprehensive panel, CardioNext, includes 85 genes implicated in inherited cardiomyopathies, arrhythmias, and other cardiovascular conditions. We have a reputation for unparalleled results reporting, sharing data while safeguarding patient privacy, and responsibly applying new technologies.